Association between serum PCSK9 and coronary heart disease in patients with type 2 diabetes mellitus

被引：0
作者：
Juan Huang
Jun-Xu Gu
Kun Wang
Ai-Min Zhang
Ting-Ting Hong
Shan-Shan Li
Xiao-Qin Yao
Ming Yang
Yue Yin
Na Zhang
Ming Su
Jia-Jia Hu
Xue-Zhi Zhang
Mei Jia
机构：
[1] Peking University International Hospital,Department of traditional Chinese medicine
[2] Peking University People’s Hospital,Department of Clinical Laboratory
[3] Central South University,Department of Clinical Laboratory, Xiangya Hospital
[4] Peking University International Hospital,Department of Clinical Laboratory
来源：
Diabetology & Metabolic Syndrome | / 15卷
关键词：
PCSK9; T2DM; Coronary heart disease; Cardiovascular events;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Association of PCSK9 Variants With the Risk of Atherosclerotic Cardiovascular Disease and Variable Responses to PCSK9 Inhibitor Therapy
    Krittanawong, Chayakrit
    Khawaja, Muzamil
    Rosenson, Robert S.
    Amos, Christopher, I
    Nambi, Vijay
    Lavie, Carl J.
    Virani, Salim S.
    CURRENT PROBLEMS IN CARDIOLOGY, 2022, 47 (07)
  • [22] Carotid atherosclerosis and its relationship to coronary heart disease and stroke risk in patients with type 2 diabetes mellitus
    Wu, Yen
    He, Jie
    Sun, Xue
    Zhao, Yi-Ming
    Lou, Han-Yu
    Ji, Xiao-Li
    Pang, Xiao-Hong
    Shan, Li-Zhen
    Kang, Ying-Xiu
    Xu, Jun
    Zhang, Song-Zhao
    Wang, Yong-Jian
    Ren, Yue-Zhong
    Shan, Peng-Fei
    MEDICINE, 2017, 96 (39)
  • [23] Association between matrix metallopeptidase 1 and type 2 diabetes mellitus coexisting with coronary heart disease in a Han Chinese population
    Ma, Y. Z.
    Jiang, Q. Y.
    Kong, D. Q.
    GENETICS AND MOLECULAR RESEARCH, 2016, 15 (02)
  • [24] Local myocardial contractility disturbances in patients with coronary heart disease and Type 2 diabetes mellitus
    Georgadze, Z. O.
    Fomina, I. G.
    Gaydamakina, N. E.
    Frolova, A. I.
    Vargina, T. S.
    Vasilyeva, A. E.
    Galanina, N. A.
    CARDIOVASCULAR THERAPY AND PREVENTION, 2007, 6 (07): : 36 - 40
  • [25] Patterns and levels of platelet glycosylation in patients with coronary heart disease and type 2 diabetes mellitus
    Li, Liping
    Qu, Chenxue
    Wu, Xuelian
    Dai, Juhua
    Lu, Yao
    Gong, Yan
    You, Ran
    Liu, Yaqi
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2018, 45 (01) : 56 - 65
  • [26] Nomogram Based on Risk Factors for Type 2 Diabetes Mellitus Patients with Coronary Heart Disease
    Shi, Rong
    Wu, Birong
    Niu, Zheyun
    Sun, Hui
    Hu, Fan
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2020, 13 : 5025 - 5036
  • [27] Variation in PCSK9 and HMGCR and Risk of Cardiovascular Disease and Diabetes
    Ference, Brian A.
    Robinson, Jennifer G.
    Brook, Robert D.
    Catapano, Alberico L.
    Chapman, M. John
    Neff, David R.
    Voros, Szilard
    Giugliano, Robert P.
    Smith, George Davey
    Fazio, Sergio
    Sabatine, Marc S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (22) : 2144 - 2153
  • [28] Patterns and levels of platelet glycosylation in patients with coronary heart disease and type 2 diabetes mellitus
    Liping Li
    Chenxue Qu
    Xuelian Wu
    Juhua Dai
    Yao Lu
    Yan Gong
    Ran You
    Yaqi Liu
    Journal of Thrombosis and Thrombolysis, 2018, 45 : 56 - 65
  • [29] Relationship between Diabetes Mellitus and Coronary Heart Disease
    Das, Rabindra Nath
    CURRENT DIABETES REVIEWS, 2016, 12 (03) : 285 - 296
  • [30] THE VALUE OF EVALUATING THE DEGREE OF CORONARY ATHEROSCLEROSIS IN CORONARY HEART DISEASE BY A5, A-FABP, AND PCSK9
    Liu, Yancai
    Jiang, Hua
    ACTA MEDICA MEDITERRANEA, 2019, 35 (05): : 2357 - 2361
12345